Rothrock J, Najib U, Ailani J, Ashina S, et al. Safety, tolerability, and efficacy of atogepant added to onabotulinumtoxinA for the preventive treatment of chronic migraine: A phase 3, multicenter, 24-week, open-label study. Cephalalgia 2026;46:3331024261429118.
PMID: 41944477